10x Genomics Inc (TXG)
26.88
-0.64
(-2.33%)
USD |
NASDAQ |
Apr 25, 16:00
26.88
0.00 (0.00%)
After-Hours: 20:00
10x Genomics Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
Date | Value |
---|---|
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.0707 |
September 30, 2019 | 0.0704 |
June 30, 2019 | 1.939 |
March 31, 2019 | |
December 31, 2018 | -0.1349 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Mar 2020
1.939
Maximum
Jun 2019
0.1095
Average
--
Median
Mar 2020
Debt to Equity Ratio Benchmarks
Teladoc Health Inc | 0.6615 |
American Shared Hospital Services | 0.7773 |
Novo Integrated Sciences Inc | 0.1478 |
Astrana Health Inc | 0.4533 |
Cryo-Cell International Inc | -1.019 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 965.14M |
Total Liabilities (Quarterly) | 224.10M |
Shareholders Equity (Quarterly) | 741.04M |
Current Ratio | 4.687 |